Public Profile

Cefa-Cilinas Biotics

Cefa-Cilinas Biotics, headquartered in India, is a prominent player in the biopharmaceutical industry, specialising in innovative biotic solutions. Founded in 2010, the company has rapidly expanded its operations across major regions in Asia, establishing a strong market presence. Cefa-Cilinas Biotics is renowned for its cutting-edge products, including probiotics and prebiotics, which are designed to enhance gut health and overall well-being. What sets them apart is their commitment to research and development, ensuring that their offerings are backed by scientific evidence and tailored to meet the evolving needs of consumers. With a focus on quality and efficacy, Cefa-Cilinas Biotics has achieved significant milestones, positioning itself as a trusted name in the biotics sector. Their dedication to innovation and customer satisfaction continues to drive their success in a competitive market.

DitchCarbon Score

How does Cefa-Cilinas Biotics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Cefa-Cilinas Biotics's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Cefa-Cilinas Biotics's reported carbon emissions

Cefa-Cilinas Biotics, headquartered in India, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the biotics industry are increasingly focusing on sustainability and climate commitments. This often includes initiatives aimed at reducing carbon footprints, enhancing energy efficiency, and transitioning to renewable energy sources. Cefa-Cilinas Biotics may be expected to align with industry standards and practices, potentially exploring avenues for future emissions tracking and reduction strategies. As the company progresses, it will be crucial to monitor any forthcoming commitments or achievements in the realm of carbon emissions and climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cefa-Cilinas Biotics's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Cefa-Cilinas Biotics is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cefa-Cilinas Biotics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

Horizon Therapeutics

US
Chemicals
Updated 11 days ago

Alufluor AB

SE
Chemicals
Updated 3 days ago

Strata-Tac Inc.

US
Chemicals
Updated 11 days ago

Badger Color Concentrates Inc

US
Chemicals
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers